{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T11:49:59Z","timestamp":1788522599736,"version":"build-2803163510"},"reference-count":20,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,3]],"date-time":"2025-08-03T00:00:00Z","timestamp":1754179200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["HHSN2612018000151"],"award-info":[{"award-number":["HHSN2612018000151"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["1NU58DP007156"],"award-info":[{"award-number":["1NU58DP007156"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014479","name":"Georgia Department of Public Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014479","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","award":["RSG-21-045-CPHPS"],"award-info":[{"award-number":["RSG-21-045-CPHPS"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006034","name":"University of Southern California","doi-asserted-by":"publisher","award":["HHSN2612018000091"],"award-info":[{"award-number":["HHSN2612018000091"]}],"id":[{"id":"10.13039\/100006034","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.urolonc.2025.07.033","type":"journal-article","created":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T11:10:19Z","timestamp":1756465819000},"page":"709.e19-709.e24","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Disparities in radiation treatment modality for prostate cancer"],"prefix":"10.1016","volume":"43","author":[{"given":"Mitchell","family":"Alameddine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oluwaseun","family":"Orikogbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Sharbaugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan G.","family":"Yabes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisy","family":"Obiora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael G.","family":"Stencel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin J.","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay M.","family":"Sabik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce L.","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2025.07.033_bib0001","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1186\/s13014-014-0275-6","article-title":"Hypofractionated radiotherapy for prostate cancer","volume":"9","author":"Hegemann","year":"2014","journal-title":"Radiat Oncol"},{"issue":"12","key":"10.1016\/j.urolonc.2025.07.033_bib0002","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1200\/JCO.2013.53.8652","article-title":"Stereotactic body radiation therapy versus intensity-modulated radiation therapy for prostate cancer: comparison of toxicity","volume":"32","author":"Yu","year":"2014","journal-title":"J Clin Oncol"},{"issue":"15","key":"10.1016\/j.urolonc.2025.07.033_bib0003","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJMoa2403365","article-title":"Phase 3 trial of stereotactic body radiotherapy in localized prostate cancer","volume":"391","author":"van As","year":"2024","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.urolonc.2025.07.033_bib0004","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/S1470-2045(22)00517-4","article-title":"Intensity-modulated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): 2-year toxicity results from an open-label, randomised, phase 3, non-inferiority trial","volume":"23","author":"Tree","year":"2022","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.urolonc.2025.07.033_bib0005","unstructured":"Network NCC. Accessed January 31, 2024, https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/prostate.pdf"},{"issue":"9","key":"10.1016\/j.urolonc.2025.07.033_bib0006","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s11920-021-01274-4","article-title":"Disparities in health care and the digital divide","volume":"23","author":"Saeed","year":"2021","journal-title":"Curr Psychiatry Rep"},{"issue":"8","key":"10.1016\/j.urolonc.2025.07.033_bib0007","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.025358","article-title":"Addressing social determinants of health and mitigating health disparities across the lifespan in congenital Heart disease: a scientific statement from the American Heart Association","volume":"11","author":"Lopez","year":"2022","journal-title":"J Am Heart Assoc"},{"issue":"8","key":"10.1016\/j.urolonc.2025.07.033_bib0008","doi-asserted-by":"crossref","first-page":"577","DOI":"10.7326\/M17-2441","article-title":"Addressing social determinants to improve patient care and promote health equity: an American College of Physicians position Paper","volume":"168","author":"Daniel","year":"2018","journal-title":"Ann Intern Med"},{"issue":"10077","key":"10.1016\/j.urolonc.2025.07.033_bib0009","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(17)30569-X","article-title":"Structural racism and health inequities in the USA: evidence and interventions","volume":"389","author":"Bailey","year":"2017","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.urolonc.2025.07.033_bib0010","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.37165","article-title":"Differential use of radiotherapy fractionation regimens in prostate cancer","volume":"6","author":"Qureshy","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10.1016\/j.urolonc.2025.07.033_bib0011","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.brachy.2021.06.148","article-title":"Trends and variations in utilization and costs of radiotherapy for prostate cancer: a SEER medicare analysis from 2007 through 2016","volume":"21","author":"Mukherjee","year":"2022","journal-title":"Brachytherapy"},{"key":"10.1016\/j.urolonc.2025.07.033_bib0012","unstructured":"SEER-Medicare linked database. Accessed December 1, 2023."},{"issue":"1","key":"10.1016\/j.urolonc.2025.07.033_bib0013","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/JU.0000000000000471","article-title":"The influence of stereotactic body radiation therapy adoption on prostate cancer treatment patterns","volume":"203","author":"Jacobs","year":"2020","journal-title":"J Urol"},{"issue":"12","key":"10.1016\/j.urolonc.2025.07.033_bib0014","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/S0895-4356(00)00256-0","article-title":"Development of a comorbidity index using physician claims data","volume":"53","author":"Klabunde","year":"2000","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.urolonc.2025.07.033_bib0015","unstructured":"Network NCC. Prostate cancer, Version 3.2012. Accessed January 1, 2025. https:\/\/jnccn.org\/view\/journals\/jnccn\/10\/9\/article-p1081.xml. 2012."},{"key":"10.1016\/j.urolonc.2025.07.033_bib0016","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.urology.2019.11.049","article-title":"The development and validation of prostate cancer-specific physician-hospital networks","volume":"138","author":"Jacobs","year":"2020","journal-title":"Urology"},{"issue":"9","key":"10.1016\/j.urolonc.2025.07.033_bib0017","doi-asserted-by":"crossref","first-page":"388.e1","DOI":"10.1016\/j.urolonc.2023.04.024","article-title":"Patterns of multispecialty care for low- and intermediate-risk prostate cancer in the use of active surveillance","volume":"41","author":"Zambrano","year":"2023","journal-title":"Urol Oncol"},{"issue":"8","key":"10.1016\/j.urolonc.2025.07.033_bib0018","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1097\/00005650-200108000-00014","article-title":"Personal, organizational, and market level influences on physicians' practice patterns: results of a national survey of primary care physicians","volume":"39","author":"Landon","year":"2001","journal-title":"Med Care"},{"issue":"1","key":"10.1016\/j.urolonc.2025.07.033_bib0019","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1001\/jama.287.1.111-JMS0102-5-1","article-title":"MSJAMA. Relationship between travel distance and utilization of breast cancer treatment in rural northern Michigan","volume":"287","author":"Meden","year":"2002","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.urolonc.2025.07.033_bib0020","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1002\/cncr.31190","article-title":"Travel distance and stereotactic body radiotherapy for localized prostate cancer","volume":"124","author":"Mahal","year":"2018","journal-title":"Cancer"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143925003059?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143925003059?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T11:17:05Z","timestamp":1772882225000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143925003059"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":20,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S1078143925003059"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2025.07.033","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Disparities in radiation treatment modality for prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2025.07.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}